Companies

Iambic Therapeutics, Inc. (IAM) SEC filings

CIK 0001997038 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Latest filings

FiledFormDescriptionPeriod
2026-10-194PRIMARY DOCUMENT2026-10-16
2026-10-19442026-10-16
2026-10-19442026-10-16
2026-10-19442026-10-16
2026-10-19442026-10-16
2026-10-168-K8-K items 5.03,7.01,9.012026-10-16
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-16442026-10-14
2026-10-15424B4424B4
2026-10-15S-8S-8
2026-10-14EFFECTEFFECT items ,,
2026-10-143PRIMARY DOCUMENT2026-10-14
2026-10-14332026-10-14
2026-10-14332026-10-14
2026-10-14332026-10-14
2026-10-14332026-10-14

Forms on file (last 1,000): 4 16, 3 13, D 5, D/A 2, 8-K 1, 424B4 1, S-8 1, EFFECT 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=IAM (0.002 USD), /gw/filings/filings?ticker=IAM&form=8-K, /gw/filings/facts?ticker=IAM&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange